Skip to main content
. Author manuscript; available in PMC: 2017 Mar 1.
Published in final edited form as: Clin Lymphoma Myeloma Leuk. 2015 Nov 24;16(3):163–168.e2. doi: 10.1016/j.clml.2015.11.016

Table 3.

Toxic effects and treatment-related mortality in the matched cohorts receiving induction therapy for AML

Variable CLDA
(n = 95)
IA
(n = 95)
P
Any grade <3 toxicity, no. (%) 51 (54) 36 (38) .03
Any grade ≥3 toxicity, no. (%) 44 (46) 59 (62)
TRM rate at 4 weeks 5% 11% .42
TRM rate at 8 weeks 14% 15% .84

TRM, treatment-related mortality.